CDMO Service
Focus Areas:
● High Potency, Cytotoxic, Niche APIs.
● Payload & Linker (PEG, PSAR, Lipid and Linker) for XDC drugs.
● Macromolecular APls （Glycans / Polypeptide）.
Our Advantages：
● Successful experience in CDMO projects, including IND, NDA, ANDA (P-lV challenge), etc.
● Proficient in global registrations: FDA, PMDA, EDQM.
● Customer-oriented, flexible cooperation model.
